Differential regulation of transforming growth factor-β receptors type I and II by platelet-derived growth factor in human dermal fibroblasts

British Journal of Dermatology

Volumn 145, Issue 4, 2001, Pages 569-575

  Czuwara Ladykowska, J ^a   Gore, E A ^a   Shegogue, D A ^a   Smith, E A ^a   Trojanowska, Maria ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Fibroblast; Mitogen activated protein kinase; Platelet derived growth factor; Systemic sclerosis; Transforming growth factor receptor types I and II

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NORMAL HUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SKIN FIBROBLAST; STEADY STATE; WESTERN BLOTTING;

ACTIVIN RECEPTORS, TYPE I; CELL CULTURE TECHNIQUES; FIBROBLASTS; FLAVONOIDS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SKIN; UP-REGULATION;

EID: 0035788742     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04443.x     Document Type: Article

References (31)

1. Heldin C-H, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999; 79: 1283-316.
2. Seifert RA, Hart CE, Phillips PE et al. Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem 1989; 264: 8771-8.
3. Heldin CH, Westermark B. Role of platelet-derived growth factor in vivo. In: The Molecular and Cellular Biology of Wound Repair (Clark RAF, ed.), 2nd edn. New York: Plenum Press, 1996; 249-73.
4. Makhluf HA, Stepniakowska J, Hoffmann S et al. IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts. J Invest Dermatol 1996; 107: 856-9.
5. Gay S, Jones RE, Huang GQ, Gay RE. Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma. J Invest Dermatol 1989; 92: 301-3.
6. Yamakage A, Kikuchi K, Smith EA et al. Selective upregulation of platelet-derived growth factor α receptors by transforming growth factor-β in scleroderma fibroblasts. J Exp Med 1992; 175: 1227-34.
7. Ludwicka A, Ohba T, Trojanowska M et al. Elevated levels of platelet-derived growth factor and transforming growth factor-β in bronchoalveolar lavage fluid from patients with scleroderma. J Rheumatol 1995; 22: 1876-83.
8. Kulozik M, Hogg A, Lankat-Buttgereit B, Krieg T. Co-localization of transforming growth factor-β2 with α1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 1990; 86: 917-22.
9. Sfikakis PP, McCune BK, Tsokos M et al. Immunohistochemical demonstration of transforming growth factor-β isoforms in the skin of patients with systemic sclerosis. Clin Immunol Immunopathol 1993; 69: 199-204.
10. Kawakami T, Ihn H, Xu W et al. Increased expression of TGF-β receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-β signaling to scleroderma phenotype. J Invest Dermatol 1998; 110: 47-51.
11. Yoshizawa M, Miyazaki H, Kojima S. Retinoids potentiate transforming growth factor-β activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-β receptors. J Cell Physiol 1998; 176: 565-73.
12. Cohen PS, Letterio JJ, Gaetano C et al. Induction of transforming growth factor-β1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuro-blastoma cell lines. Cancer Res 1995; 55: 2380-6.
13. Falk LA, De Benedetti F, Lohrey N et al. Induction of transforming growth factor-β1 (TGF-β1) receptor expression and TGF-β1 protein production in retinoic acid-treated HL-60 cells: Possible TGF-β1-mediated autocrine inhibition. Blood 1991; 77: 1248-55.
14. Koli KM, Arteaga CL. Processing of the transforming growth factor β type I and II receptors. J Biol Chem 1997; 272: 6423-7.
15. Quan T, He T, Voorhees JJ, Fisher GJ. Ultraviolet irradiation blocks cellular responses to transforming growth factor-β by down-regulating its type-II receptor and inducing Smad7. J Biol Chem 2001; 276: 26349-56.
16. Lubinus M, Meier KE, Smith EA et al. Independent effects of platelet-derived growth factor isoforms on mitogen-activated protein kinase activation and mitogenesis in human dermal fibroblasts. J Biol Chem 1994; 269: 9822-5.
17. Rosenkranz S, Kazlaukas A. Evidence for distinct signaling properties and biological responses induced by the PDGF receptor α and β subtypes. Growth Factors 1999; 16: 201-16.
18. Yu J, Deuel TF, Kim HR. Platelet-derived growth factor (PDGF) receptor-α activates c-Jun NH2-terminal kinase-1 and antagonizes PDGF receptor-β-induced phenotypic transformation. J Biol Chem 2000; 275: 19076-82.
19. Hart CE, Bailey M, Curtis DA et al. Purification of PDGF-AB and PDGF-BB from human platetet extracts and identification of all three PDGF dimers in human platelets. Biochemistry 1990; 29: 166-72.
20. Soma Y, Dvonch V, Grotendorst G. Platelet-derived growth factor AA homodimer is the predominant isoform in human platelets and acute human wound fluid. FASEB J 1992; 6: 2996-3001.
21. Dvonch VM, Murphey RJ, Matsuoka J, Grotendorst GR. Changes in growth factor levels in human wound fluid. Surgery 1992; 112: 18-23.
22. Pierce GF, Tarpley JE, Tseng J et al. Detection of platelet-derived growth factor (PDGF) -AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest 1995; 96: 1336-50.
23. Ichiki Y, Smith EA, LeRoy EC, Trojanowska M. Different effects of basic fibroblast growth factor and transforming growth factor-β on the two platelet-derived growth factor receptors' expression in scleroderma and human dermal fibroblasts. J Invest Dermatol 1995; 104: 124-7.
24. Kikuchi K, Kadono T, Ihn H et al. Growth regulation in scleroderma fibroblasts: increased response to transforming growth factor-β. J Invest Darmatol 1995; 105: 128-32.
25. Bonner JC, Goodell AL, Coin PG et al. Chrysolite asbestos upregulates gene expression and production of α receptors for platelet-derived growth factor (PDGF-AA) on rat lung fibroblasts. J Clin Invest 1993; 92: 425-30.
26. Haisa M, Okochi H, Grotendorst GR. Elevated levels of PDGF α receptors in keloid fibroblasts contribute to the enhanced response to PDGF. J Invest Dermatol 1994; 103: 560-3.
27. McCaffrey TA. TGF-βs and TGF-β receptors in atherosclerosis. Cytokine Growth Factor Rev 2000; 11: 103-14.
28. Roulot D, Sevcsik AM, Coste T et al. Role of transforming growth factor-β type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats. Hepatology 1999; 29: 1730-8.
29. Hong SW, Isono M, Chen S et al. Increased glomerular and tubular expression of transforming growth factor-β1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am J Pathol 2001; 158: 1653-63.
30. Frank S, Madlener M, Werner S. Transforming growth factors β1, β2, and β3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 1996; 271: 10188-93.
31. Feng XH, Filvaroff EH, Derynck R. Transforming growth factor-β (TGFβ) -induced down-regulation of cyclin A expression requires a functional TGFβ receptor complex. Characterization of chimeric and truncated type I and type II receptors. J Biol Chem 1995; 270: 24237-45.